Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19James J DiNicolantonio, Jorge Barroso-Arranda, Mark McCarty6 September 2020
Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?Alex Stevenson, Ali Kirresh, Samuel Conway, Laura White, Mahmood Ahmad, Callum Little19 August 2020
Susceptibility and prognosis of COVID-19 patients with cardiovascular diseaseBrian Xiangzhi Wang25 June 2020
COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic responsePaul MacDaragh Ryan, Noel Caplice11 June 2020
Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidaseJames J DiNicolantonio, Mark McCarty11 June 2020